155. Acceptance and Implementation of 2021 CDC Guidelines for Treatment of Uncomplicated Urogenital Chlamydial Infections by Adolescent Medicine Providers

In 2021, the CDC recommended a major change in the recommendations for treatment of urogenital chlamydia infections in adolescents and adults. These changes were based on studies that found that single-dose azithromycin (AZI), was not as effective as 7-days doxycycline (DOX) for treatment of rectal infection in men who have sex with men. There are questions if these guidelines are generalizable to adolescents. There are concerns about tolerance and compliance; DOX is associated with higher rate of side effects and there may be less compliance with a 7-day, twice/day regimen.
Source: Journal of Adolescent Health - Category: Child Development Authors: Source Type: research